Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 21 July 2009
Vol. 2, Issue 80, p. ra37
[DOI: 10.1126/scisignal.1162191]

RESEARCH ARTICLES

Intracellular Delivery of a Cell-Penetrating SOCS1 that Targets IFN-{gamma} Signaling

Antonio DiGiandomenico, Lukasz S. Wylezinski, and Jacek Hawiger*

Department of Microbiology and Immunology, Vanderbilt University Medical Center, 1161 21st Avenue South, Nashville, TN 37232–2363, USA.

Abstract: Suppressor of cytokine signaling–1 (SOCS1) is an intracellular inhibitor of the Janus kinase–signal transducer and activator of transcription (JAK-STAT) pathway that couples interferon-{gamma} (IFN-{gamma}) signaling to the nucleus. Because several inflammatory diseases are associated with uncontrolled IFN-{gamma} signaling, we engineered a recombinant cell-penetrating SOCS1 (CP-SOCS1) to target this pathway. Here, we show that CP-SOCS1, analogous to endogenous SOCS1, interacted with components of the IFN-{gamma} signaling complex and functionally attenuated the phosphorylation of STAT1, which resulted in the subsequent inhibition of the production of proinflammatory chemokines and cytokines. Thus, controlled, intracellular delivery of recombinant CP-SOCS1 boosted the anti-inflammatory potential of the cell by restoring the homeostatic balance between pro- and anti-inflammatory signaling. This approach to controlling signal transduction has potential use for therapeutic targeting of signaling pathways associated with inflammatory diseases.

* To whom correspondence should be addressed. E-mail: jacek.hawiger{at}vanderbilt.edu

Citation: A. DiGiandomenico, L. S. Wylezinski, J. Hawiger, Intracellular Delivery of a Cell-Penetrating SOCS1 that Targets IFN-{gamma} Signaling. Sci. Signal. 2, ra37 (2009).

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Interferon-{gamma} biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells.
R. Satou, K. Miyata, R. A. Gonzalez-Villalobos, J. R. Ingelfinger, L. G. Navar, and H. Kobori (2012)
FASEB J 26, 1821-1830
   Abstract »    Full Text »    PDF »
A new experimental murine model for lipopolysaccharide-mediated lethal shock with lung injury.
T. Yokochi (2012)
Innate Immunity 18, 364-370
   Abstract »    Full Text »    PDF »
Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation.
S. Bhattacharyya, Y. Zhao, T. W. H. Kay, and L. J. Muglia (2011)
PNAS 108, 9554-9559
   Abstract »    Full Text »    PDF »
Extended Anti-inflammatory Action of a Degradation-resistant Mutant of Cell-penetrating Suppressor of Cytokine Signaling 3.
T. C. Fletcher, A. DiGiandomenico, and J. Hawiger (2010)
J. Biol. Chem. 285, 18727-18736
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882